Mineralys Therapeutics In...
9.53
0.41 (4.50%)
At close: Jan 15, 2025, 9:56 AM

Mineralys Therapeutics Inc. Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for MLYS stock have an median target of 30, with a low estimate of 30 and a high estimate of 30. The median target predicts an increase of 214.80% from the current stock price of 9.53.

Analyst Consensus: Buy
Target Low Average Median High
Price $30 $30 $30 $30
Change 214.80% 214.80% 214.80% 214.80%

AI Analyst Report

HC Wainwright & Co. reaffirmed a Buy rating for Mi... Unlock content with Pro Subscription

Updated Nov 12, 2024

Rating Apr 24Jul 24Aug 24Oct 24Nov 24
Strong Buy 00000
Buy 11111
Hold 00000
Sell 00000
Strong Sell 00000
Total 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-3.69
from -1.99
Increased by -85.4%
EPS Next Year
-3.85
from -3.69
Increased by -4.3%